Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Once-daily ceftriaxone for skin and soft tissue infections.

Literature DB >> 4004197

Once-daily ceftriaxone for skin and soft tissue infections.

Abstract

We prospectively compared once-daily administration of ceftriaxone with cefazolin given every 8 h for the treatment of skin and soft tissue infections. Thirty-one patients received cefazolin for a mean of 4.5 days, and 26 patients received ceftriaxone for a mean of 4.0 days. All patients had a satisfactory response. Adverse reactions were few and reversible. Ceftriaxone given as a single daily intramuscular injection is effective therapy for skin and soft tissue infections.

Entities: Chemical Species

Mesh：

Substances：

Year: 1985 PMID： 4004197 PMCID： PMC180114 DOI： 10.1128/AAC.27.4.648

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

9 in total

1. Ceftizoxime compared with cefamandole for treatment of soft tissue infections.

Authors: J Mills; G Slutkin; D Klein; W Schecter
Journal: J Antimicrob Chemother Date: 1982-11 Impact factor: 5.790

2. Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluents.

Authors: I H Patel; R E Weinfeld; J Konikoff; M Parsonnet
Journal: Antimicrob Agents Chemother Date: 1982-06 Impact factor: 5.191

3. Cost comparisons among antimicrobial agents.

Authors: M Dudley; S Barriere; J Mills
Journal: N Engl J Med Date: 1982-09-09 Impact factor: 91.245

4. Skin and soft tissue polymicrobial infections from intravenous abuse of drugs.

Authors: D Webb; H Thadepalli
Journal: West J Med Date: 1979-03

5. Home intravenous antibiotic therapy: a team approach.

Authors: S J Rehm; A J Weinstein
Journal: Ann Intern Med Date: 1983-09 Impact factor: 25.391

6. Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.

Authors: H C Neu; N J Meropol; K P Fu
Journal: Antimicrob Agents Chemother Date: 1981-03 Impact factor: 5.191

7. Intravenous antibiotic therapy in an outpatient setting.

Authors: D M Poretz; L J Eron; R I Goldenberg; A F Gilbert; J Rising; S Sparks; C E Horn
Journal: JAMA Date: 1982-07-16 Impact factor: 56.272

8. Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections.

Authors: M J Maslow; J F Levine; A A Pollock; M S Simberkoff; J J Rahal
Journal: Antimicrob Agents Chemother Date: 1982-07 Impact factor: 5.191

9. Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative.

Authors: T C Eickhoff; J Ehret
Journal: Antimicrob Agents Chemother Date: 1981-03 Impact factor: 5.191

9 in total

6 in total

1. Ceftriaxone. A pharmacoeconomic evaluation of its use in the treatment of serious infections.

Authors: R Davis; H M Bryson
Journal: Pharmacoeconomics Date: 1994-09 Impact factor: 4.981

2. In vitro activity of ceftriaxone and other cephalosporins against 602 clinical isolates of staphylococci from geographically diverse medical centers.

Authors: M A Pfaller; A L Barry; L D Sabath; B N Kreiswirth; P R Murray; P C Fuchs; J C McLaughlin
Journal: Eur J Epidemiol Date: 1993-11 Impact factor: 8.082

Review 3. Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.

Authors: R N Brogden; A Ward
Journal: Drugs Date: 1988-06 Impact factor: 9.546